The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Apigenin and cancer chemoprevention: Progress, potential and promise (Review)
Open accessAbstract
Cancer is one of the major public health burdens in the United States and in other developed countries, causing approximately 7 million deaths every year worldwide. Cancer rates vary dramatically in different regions and populations around the globe, especially between developing and developed nations. Changes in cancer prevalence patterns occur within regions as their populations age or become progressively urbanized. Migration has also contributed to such variations as changes in dietary habits influence cancer rates. These epidemiologic findings strongly suggest that cancer rates are influenced by environmental factors including diet, which is largely preventable. Approaches to prevent cancer include overlapping strategies viz. chemoprevention or dietary cancer prevention. Chemoprevention aims at prevention or reversal of the initiation phase of carcinogenesis or arrest at progression of carcinogenesis through the administration of naturally occurring constituents or pharmacological agents. Cancer prevention through diet may be largely achievable by increased consumption of fruits and vegetables. Considerable attention has been devoted to identifying plant-derived dietary agents which could be developed as promising chemopreventives. One such agent is apigenin. A naturally occurring plant flavone (4', 5, 7,-trihydroxyflavone) abundantly present in common fruits and vegetables including parsley, onions, oranges, tea, chamomile, wheat sprouts and some seasonings. Apigenin has been shown to possess remarkable anti-inflammatory, antioxidant and anti-carcinogenic properties. In the last few years, significant progress has been made in studying the biological effects of apigenin at cellular and molecular levels. This review examines the cancer chemopreventive effects of apigenin in an organ-specificity format, evaluating its limitations and its considerable potential for development as a cancer chemopreventive agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyphenols: Food sources and bioavailability
Manach, C., Scalbert, A., Morand, C., Rémésy, C., & Jiménez, L. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.727 · Cited by 8,175
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016
Flavonoid intake and risk of chronic diseases
Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., Hakulinen, T., & Aromaa, A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.3.560 · Cited by 1,752
Dietary agents in cancer prevention: flavonoids and isoflavonoids
Birt, D. F., Hendrich, S., & Wang, W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00137-1 · Cited by 1,171
Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man
Hollman, P. C. H., van Trijp, J. M. P., Buysman, M. N. C. P., v.d. Gaag, M. S., Mengelers, M. J. B., de Vries, J. H. M., & Katan, M. B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01367-7 · Cited by 782
Fruit and Vegetable Intakes and Prostate Cancer Risk
Cohen, J. H., Kristal, A. R., & Stanford, J. L. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.61 · Cited by 709
Cancer preventive effects of flavonoids—a review
Le Marchand, L. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00186-5 · Cited by 583
Fruit, Vegetables, Dietary Fiber, and Risk of Colorectal Cancer
Terry, P., Giovannucci, E., Michels, K. B., Bergkvist, L., Hansen, H., Holmberg, L., & Wolk, A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.7.525 · Cited by 579
Liang, Y.-C., Huang, Y.-T., Tsai, S.-H., Lin-Shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1945 · Cited by 572
Brusselmans, K., Vrolix, R., Verhoeven, G., & Swinnen, J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408177200 · Cited by 474
Wang, I.-K., Lin-Shiau, S.-Y., & Lin, J.-K. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00168-9 · Cited by 461
Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents
Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., et al. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.467s · Cited by 441
Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
Fang, J., Xia, C., Cao, Z., Zheng, J. Z., Reed, E., & Jiang, B.-H. (2005) · The FASEB Journal · doi:10.1096/fj.04-2175com · Cited by 312
Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells
Chen, D., Daniel, K. G., Chen, M. S., Kuhn, D. J., Landis-Piwowar, K. R., & Dou, Q. P. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.022 · Cited by 306
Wei, H., Tye, L., Bresnick, E., & Birt, D. F. (1990) · PubMed · Cited by 299
Gupta, S., Afaq, F., & Mukhtar, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205474 · Cited by 295
Self-citationCell-Cycle Arrest at G2/M and Growth Inhibition by Apigenin in Human Colon Carcinoma Cell Lines
Wang, W., Heideman, L., Chung, C. S., Pelling, J. C., Koehler, K. J., & Birt, D. F. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200006)28:2<102::aid-mc6>3.0.co;2-2 · Cited by 277
Dietary flavonoids and cancer risk in the Zutphen elderly study
Hertog, M. G. L., Feskens, E. J. M., Hollman, P. C. H., Katan, M. B., & Kromhout, D. (1994) · Nutrition and Cancer · doi:10.1080/01635589409514342 · Cited by 276
Gupta, S., Afaq, F., & Mukhtar, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5672 · Cited by 269
Self-citationFlavonoids Inhibit Cell Growth and Induce Apoptosis in B16 Melanoma 4A5 Cells
IWASHITA, K., KOBORI, M., YAMAKI, K., & TSUSHIDA, T. (2000) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.64.1813 · Cited by 255
Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells
Wang, C., & Kurzer, M. S. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514582 · Cited by 253
Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition
Chen, J., Lin, H., & Hu, M. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046409 · Cited by 248
Way, T.-D., Kao, M.-C., & Lin, J.-K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305529200 · Cited by 243
Flavonoids activate wild-type p53.
Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G., & Hess, R. D. (1996) · PubMed · Cited by 223
Birt, D. F., Mitchell, D. L., Gold, B. I., Pour, P. M., & Pinch, H. C. (1997) · PubMed · Cited by 201
Liu, L.-Z., Fang, J., Zhou, Q., Hu, X., Shi, X., & Jiang, B.-H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011254 · Cited by 198
Gray, G. E., Pike, M. C., & Henderson, B. E. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.1 · Cited by 194
Hirano, T., Oka, K., & Akiba, M. (1989) · PubMed · Cited by 193
Flavonoids and Breast Cancer Risk in Italy
Bosetti, C., Spertini, L., Parpinel, M., Gnagnarella, P., Lagiou, P., Negri, E., Franceschi, S., Montella, M., Peterson, J., Dwyer, J., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0838 · Cited by 184
Mennen, L. I., Sapinho, D., de Bree, A., Arnault, N., Bertrais, S., Galan, P., & Hercberg, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.4.923 · Cited by 182
Yin, F., Giuliano, A., Law, R. E., & Herle, A. J. V. (2001) · PubMed · Cited by 181
Gradolatto, A., Basly, J.-P., Berges, R., Teyssier, C., Chagnon, M.-C., Siess, M.-H., & Canivenc-Lavier, M.-C. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000893 · Cited by 179
Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells
Zheng, P.-W., Chiang, L.-C., & Lin, C.-C. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.08.023 · Cited by 172
Kim, M. H. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10543 · Cited by 168
Sanderson, J. T. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh257 · Cited by 165
Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin
Lepley, D. M., & Pelling, J. C. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199707)19:2<74::aid-mc2>3.0.co;2-l · Cited by 164
Flavonoids Suppress Androgen-Independent Human Prostate Tumor Proliferation
Knowles, L. M., Zigrossi, D. A., Tauber, R. A., Hightower, C., & Milner, J. A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc381_16 · Cited by 161
Ohno, S., Shinoda, S., Toyoshima, S., Nakazawa, H., Makino, T., & Nakajin, S. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00021-3 · Cited by 160
Cancer chemoprevention: scientific promise, clinical uncertainty
Sporn, M. B., & Liby, K. T. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0319 · Cited by 158
Flavonoid intake and breast cancer risk: a case–control study in Greece
Peterson, J., Λάγιου, Π., Samoli, E., Lagiou, A., Katsouyanni, K., Vecchia, C. L., Dwyer, J. T., & Trichopoulos, D. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601271 · Cited by 150
Collins‐Burow, B. M., Burow, M. E., Duong, B. N., & McLachlan, J. A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_13 · Cited by 149
Monasterio, A., Urdaci, M. C., Pinchuk, I. V., López-Moratalla, N., & Martínez-Irujo, J. J. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc5001_12 · Cited by 146
Wang, W., VanAlstyne, P. C., Irons, K. A., Chen, S., Stewart, J. W., & Birt, D. F. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4801_14 · Cited by 141
Wang, C., & Kurzer, M. S. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514686 · Cited by 141
Zhang, S., Yang, X., & Morris, M. E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033015.84146.4c · Cited by 138
Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells
O’Prey, J., Brown, J. E., Fleming, J., & Harrison, P. R. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.007 · Cited by 137
Shukla, S., & Gupta, S. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.10168 · Cited by 125
Self-citationSuppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor
Reiners, J. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1561 · Cited by 108
Kuo, M., Lee, K.-C., & Lin, J. (1992) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(92)90119-m · Cited by 107
Yin, F., Giuliano, A. E., & Herle, A. J. V. (2000) · PubMed · Cited by 104
McVean, M., Xiao, H., Isobe, K., & Pelling, J. C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.633 · Cited by 104
Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway
Takagaki, N., Sowa, Y., Oki, T., Nakanishi, R., Yogosawa, S., & Sakai, T. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.1.185 · Cited by 104
An overview of targeted treatments in cancer
Abou-Jawde, R. M., Choueiri, T. K., Alemany, C. A., & Mekhail, T. M. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80209-6 · Cited by 101
Dietary Agents in the Chemoprevention of Prostate Cancer
Shukla, S., & Gupta, S. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5301_3 · Cited by 100
Self-citationSteroid activities comparison of natural and food wrap compounds in human breast cancer cell lines
Stroheker, T., Picard, K., Lhuguenot, J., Lavier, M.-C. C., & Chagnon, M. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.01.012 · Cited by 96
Kim, H.-Y., Kim, O., & Sung, M. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719296 · Cited by 95
Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
Svehlikova, V. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh169 · Cited by 94
Dross, R. V., Xue, Y. Z., Knudson, A., & Pelling, J. C. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3800s · Cited by 90
Antifertility and hormonal properties of flavones of Striga orobanchioides
HIREMATH, S. P., Badami, S., Hunasagatta, S. K., & Patil, S. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00723-2 · Cited by 88
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions
Piantelli, M., Rossi, C., Iezzi, M., La Sorda, R., Iacobelli, S., Alberti, S., & Natali, P. G. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20510 · Cited by 85
Novel Approaches for Targeted Cancer Therapy
Guillemard, V., & Saragovi, H. U. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332989 · Cited by 81
DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
Chen, J., Wang, S., Jia, X., Bajimaya, S., Lin, H., Tam, V. H., & Hu, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003673 · Cited by 80
Advances in Radiation Oncology
Elshaikh, M. A., Ljungman, M. E., Haken, R. K. T., & Lichter, A. S. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131431 · Cited by 76
Current developments of immunotherapy in the clinic
Antonia, S. J., Mulé, J. J., & Weber, J. S. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.012 · Cited by 74
Crowell, J. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.016 · Cited by 72
Eaton, E. A., Walle, U. K., Lewis, A. J., Hudson, T., Wilson, A. A., & Walle, T. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07302-7 · Cited by 67
Catecholic Flavonoids Acting as Telomerase Inhibitors
Menichincheri, M., Ballinari, D., Bargiotti, A., Bonomini, L., Ceccarelli, W., D’Alessio, R., Fretta, A., Moll, J., Polucci, P., Soncini, C., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040810b · Cited by 59
The free radical scavenging activity of four flavonoids determined by the comet assay.
Horváthová, K., Novotny, L., & Vachálková, A. (2003) · PubMed · Cited by 58
Mounho, B. J., & Thrall, B. D. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8740 · Cited by 48
Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma
Torkin, R., Lavoie, J.-F., Kaplan, D. R., & Yeger, H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1.4.1 · Cited by 46
Inhibitory effects of apigenin on the growth of gastric carcinoma SGC-7901 cells
Wu, K. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i29.4461 · Cited by 38
Engelmann, C., Blot, E., Panis, Y., Bauer, S., Trochon, V., Nagy, H., Lu, H., & Soria, C. (2002) · Phytomedicine · doi:10.1078/09447110260573100 · Cited by 34
Molecularly targeted agents: Their promise as cancer chemopreventive interventions
Thiery-Vuillemin, A., Nguyen, T., Pivot, X. B., Spano, J., Dufresnne, A., & Soria, J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.005 · Cited by 34
Cancer chemoprevention: lessons learned and future directions
Brenner, D. E., & Gescher, A. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602765 · Cited by 32
PKC-mediated survival signaling in breast carcinoma cells: A role for MEK1-AP1 signaling
Weldon, C., McKee, A., Collins-Burow, B., Melnik, L., Scandurro, A., McLachlan, J., Burow, M., & Beckman, B. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.3.763 · Cited by 28
Cited by
The Therapeutic Potential of Apigenin
Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E. B., Novellino, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061305 · Cited by 1,238
Apigenin: A Promising Molecule for Cancer Prevention
Shukla, S., & Gupta, S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0089-7 · Cited by 820
Self-citationGinwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 588
Recent advances in understanding the anti-diabetic actions of dietary flavonoids
Babu, P. V. A., Liu, D., & Gilbert, E. R. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.003 · Cited by 544
Ferreira, J. F. S., Luthria, D. L., Sasaki, T., & Heyerick, A. (2010) · Molecules · doi:10.3390/molecules15053135 · Cited by 531
Metadata
- Authors
- Patel, D., Shukla, S., & Gupta, S.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2007-01-01
- Volume
- 30
- Issue
- 1
- Pages
- 233-45
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2078777597
- Cited by
- 526
- References
- 77
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.